CN110141589B - 一种山荷叶提取物及其制备方法和应用 - Google Patents
一种山荷叶提取物及其制备方法和应用 Download PDFInfo
- Publication number
- CN110141589B CN110141589B CN201910537889.XA CN201910537889A CN110141589B CN 110141589 B CN110141589 B CN 110141589B CN 201910537889 A CN201910537889 A CN 201910537889A CN 110141589 B CN110141589 B CN 110141589B
- Authority
- CN
- China
- Prior art keywords
- folium
- extract
- preparation
- methanol
- kaempferiae
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000284 extract Substances 0.000 title claims abstract description 40
- 238000002360 preparation method Methods 0.000 title claims abstract description 22
- 238000000605 extraction Methods 0.000 title description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims abstract description 102
- 239000000706 filtrate Substances 0.000 claims abstract description 16
- 238000001914 filtration Methods 0.000 claims abstract description 13
- 230000001093 anti-cancer Effects 0.000 claims abstract description 12
- 239000003814 drug Substances 0.000 claims abstract description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 8
- 238000002156 mixing Methods 0.000 claims abstract description 5
- 230000002401 inhibitory effect Effects 0.000 claims description 10
- 241000220151 Saxifragaceae Species 0.000 claims description 3
- 239000002994 raw material Substances 0.000 claims description 3
- 238000011084 recovery Methods 0.000 claims description 2
- 235000011447 Geum Nutrition 0.000 claims 1
- 241000220313 Geum Species 0.000 claims 1
- 230000004663 cell proliferation Effects 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 13
- 230000005764 inhibitory process Effects 0.000 abstract description 11
- 210000001072 colon Anatomy 0.000 abstract description 6
- 229940079593 drug Drugs 0.000 abstract description 5
- 239000002246 antineoplastic agent Substances 0.000 abstract description 2
- 229940041181 antineoplastic drug Drugs 0.000 abstract description 2
- 210000004027 cell Anatomy 0.000 description 25
- 239000000243 solution Substances 0.000 description 22
- 238000000034 method Methods 0.000 description 9
- 230000035755 proliferation Effects 0.000 description 9
- 240000002853 Nelumbo nucifera Species 0.000 description 8
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 8
- GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 description 7
- 201000011510 cancer Diseases 0.000 description 7
- 229960002949 fluorouracil Drugs 0.000 description 7
- 238000002137 ultrasound extraction Methods 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 5
- 206010009944 Colon cancer Diseases 0.000 description 4
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 4
- 230000003211 malignant effect Effects 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 4
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 230000003698 anagen phase Effects 0.000 description 3
- 230000009702 cancer cell proliferation Effects 0.000 description 3
- 230000034994 death Effects 0.000 description 3
- 231100000517 death Toxicity 0.000 description 3
- 239000012091 fetal bovine serum Substances 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 238000009098 adjuvant therapy Methods 0.000 description 2
- 238000011319 anticancer therapy Methods 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 238000007918 intramuscular administration Methods 0.000 description 2
- 238000007912 intraperitoneal administration Methods 0.000 description 2
- 238000001990 intravenous administration Methods 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 239000000419 plant extract Substances 0.000 description 2
- 238000002791 soaking Methods 0.000 description 2
- 229960005322 streptomycin Drugs 0.000 description 2
- 210000004881 tumor cell Anatomy 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 239000012980 RPMI-1640 medium Substances 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000002238 attenuated effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- -1 cataplasma Substances 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 238000001516 cell proliferation assay Methods 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000007917 intracranial administration Methods 0.000 description 1
- 238000007913 intrathecal administration Methods 0.000 description 1
- 238000007914 intraventricular administration Methods 0.000 description 1
- 229940040145 liniment Drugs 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000011127 radiochemotherapy Methods 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Botany (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910537889.XA CN110141589B (zh) | 2019-06-20 | 2019-06-20 | 一种山荷叶提取物及其制备方法和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910537889.XA CN110141589B (zh) | 2019-06-20 | 2019-06-20 | 一种山荷叶提取物及其制备方法和应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110141589A CN110141589A (zh) | 2019-08-20 |
CN110141589B true CN110141589B (zh) | 2021-10-15 |
Family
ID=67595946
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910537889.XA Active CN110141589B (zh) | 2019-06-20 | 2019-06-20 | 一种山荷叶提取物及其制备方法和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110141589B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116139184B (zh) * | 2022-12-15 | 2024-06-25 | 贺州学院 | 一种具有促进肠道有益菌生长的山荷叶取物及其制备方法和应用 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101974006A (zh) * | 2010-10-19 | 2011-02-16 | 南京泽朗医药科技有限公司 | 一种从山荷叶中提取鬼臼毒素的方法 |
-
2019
- 2019-06-20 CN CN201910537889.XA patent/CN110141589B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101974006A (zh) * | 2010-10-19 | 2011-02-16 | 南京泽朗医药科技有限公司 | 一种从山荷叶中提取鬼臼毒素的方法 |
Non-Patent Citations (3)
Title |
---|
山荷叶的化学成分;金永日等;《吉林大学学报(理学版)》;20111231;第49卷(第02期);340-342 * |
槲皮苷药理活性研究进展;杨琳;《亚太传统医药》;20150331;第11卷(第06期);61-63 * |
金永日等.山荷叶的化学成分.《吉林大学学报(理学版)》.2011,第49卷(第02期),340-342. * |
Also Published As
Publication number | Publication date |
---|---|
CN110141589A (zh) | 2019-08-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110141589B (zh) | 一种山荷叶提取物及其制备方法和应用 | |
CN108434399A (zh) | 一种防治肿瘤的中药组合物及制备方法 | |
CN110623966B (zh) | 一种雷公藤甲素及其组合物用于制备抗食管癌药物的用途 | |
CN102125571A (zh) | 一种达玛烷苷元复合物及其应用 | |
KR102269816B1 (ko) | 대마 추출물을 유효성분으로 포함하는 항암, 항암 부작용 저하 및 암 전이 억제용 조성물 | |
KR20200012363A (ko) | 어수리 지하부 및 사상자 혼합 추출물을 유효성분으로 포함하는 비만의 예방, 개선 또는 치료용 조성물 | |
CN110201015B (zh) | 锈腐病人参提取物在制备用于***的药物中的应用 | |
CN114848786A (zh) | 一种抗癌、增加免疫力的复方三参汤 | |
TWI811478B (zh) | 牛樟芝萃取物、牛樟芝組合物的製備方法及醫藥組合物 | |
CN109172549B (zh) | 一种抗肿瘤活性组合物及其应用 | |
CN113599403B (zh) | 西番莲提取物在制备防治乳腺癌药物中的应用 | |
CN108853308B (zh) | 一种重楼总皂苷-木鳖子药物组合及制备方法 | |
CN101007047B (zh) | 一种抗肿瘤药物组合物及其制备方法 | |
CN103961427A (zh) | 一种治疗2型糖尿病的金露梅提取物及其制备方法 | |
KR102668368B1 (ko) | 흑법사 추출물을 유효성분으로 포함하는 암 예방 또는 치료용 조성물 | |
CN104529968B (zh) | 一种抗肿瘤二萜类化合物,其药物组合物及其制备方法和用途 | |
US11564961B2 (en) | Preparation method of a cannabis extract composition for reduction of side effects of anticancer treatment, or cancer metastasis suppression | |
KR102590151B1 (ko) | 한약재 복합 추출물을 유효 성분으로 포함하는 췌장암 예방 또는 치료용 약학적 조성물 | |
CN109602775B (zh) | 乳苣醇提物在制备抗乳腺癌药物中的用途 | |
CN114601852B (zh) | 灵芝子实体高压超临界co2提取物制备的抗肿瘤药物 | |
CN109432118B (zh) | 白鹤藤碱在生物医药中的应用 | |
CN101829173A (zh) | 牛角瓜叶提取物的制备及抗肿瘤药物的应用 | |
CN109453249B (zh) | 防治药物性肝损伤的药物组合物及不同剂型的制备方法 | |
CN109364092B (zh) | 一种白鹤藤碱的用途 | |
CN101347510A (zh) | 山乌龟提取物在制备抗肿瘤药物中的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20190820 Assignee: Guangxi Kanglin Chemical Reagent Co.,Ltd. Assignor: HEZHOU University Contract record no.: X2023980046440 Denomination of invention: A mountain lotus leaf extract and its preparation method and application Granted publication date: 20211015 License type: Common License Record date: 20231108 Application publication date: 20190820 Assignee: Zhongshan County Fuqiang Agricultural Planting Professional Cooperative Assignor: HEZHOU University Contract record no.: X2023980046398 Denomination of invention: A mountain lotus leaf extract and its preparation method and application Granted publication date: 20211015 License type: Common License Record date: 20231108 Application publication date: 20190820 Assignee: Guangxi Fuchuan Rongrong Agricultural Development Co.,Ltd. Assignor: HEZHOU University Contract record no.: X2023980046375 Denomination of invention: A mountain lotus leaf extract and its preparation method and application Granted publication date: 20211015 License type: Common License Record date: 20231108 Application publication date: 20190820 Assignee: Fuchuan Kangzhuang Breeding Family Farm Assignor: HEZHOU University Contract record no.: X2023980046366 Denomination of invention: A mountain lotus leaf extract and its preparation method and application Granted publication date: 20211015 License type: Common License Record date: 20231108 Application publication date: 20190820 Assignee: GUANGXI ZHONGSHAN FUQIANG YAYAO HUAXIANG AGRICULTURE CO.,LTD. Assignor: HEZHOU University Contract record no.: X2023980046356 Denomination of invention: A mountain lotus leaf extract and its preparation method and application Granted publication date: 20211015 License type: Common License Record date: 20231108 |
|
EE01 | Entry into force of recordation of patent licensing contract |